Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Targeting EBV-positive B- and T/NK-cell lymphomas

Heather M. Long

Blood (2018) 132 (22): 2315–2316.

https://doi.org/10.1182/blood-2018-10-878587

Published: 2018

Journal Articles

EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation

Lauren P. McLaughlin, Rayne Rouce, Stephen Gottschalk, Vicky Torrano, George Carrum, Meng-Fen Wu, Fahmida Hoq, Bambi Grilley, Andrea M. Marcogliese, Patrick J. Hanley, Adrian P. Gee, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop, Catherine M. Bollard

Blood (2018) 132 (22): 2351–2361.

https://doi.org/10.1182/blood-2018-07-863654

Published: 2018

Journal Articles

Biological Significance of the Immumoproteasome Subunits Mecl-1 and LMP-2 in Diffuse Large B-Cell Lymphoma.

Lan V Pham, PhD, Alex Rollo, Archito T. Tamayo, MS, John Lee, MD, Zhuang Zuo, MD, Ph.D, Luhong Sun, MD, PhD, Liang Zhang, MD, PhD, Zhishou Ou, MD, Luis E Fayad, MD, Michael Wang, M.D., Richard J. Ford, MD, PhD

Blood (2012) 120 (21): 2717.

https://doi.org/10.1182/blood.V120.21.2717.2717

Published: 2012

Journal Articles

Towards Phase 2/3 Trials for Epstein - Barr Virus (EBV)-Associated Malignancies,

Jun Ando, MD, PhD, Minhtran Charlotte Ngo, Sravya Ennamuri, Jiali Sun, PhD, Helen E. Heslop, MD, Catherine M. Bollard, MD, Carl H. June, MD, Ann M. Leen, PhD, Stephen Gottschalk, MD, Cliona M. Rooney, PhD

Blood (2011) 118 (21): 4043.

https://doi.org/10.1182/blood.V118.21.4043.4043

Published: 2011

Journal Articles

A Functional In Vivo RNAi screen Involving Jumonji C Domain Containing Candidates Unravels Kdm5b As a Negative Modulator of Hematopoietic Stem Cell Self-Renewal

Sonia Cellot, MD, Kristin J Hope, PhD, Martin Sauvageau, PhD, Jalila Chagraoui, PhD, Eric Deneault, PhD, Tara MacRae, Nadine Mayotte, Guy Sauvageau, MD, PhD

Blood (2011) 118 (21): 385.

https://doi.org/10.1182/blood.V118.21.385.385

Published: 2011

Journal Articles

Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas

Katerina Vrzalikova, Martina Vockerodt, Sarah Leonard, Andrew Bell, Wenbin Wei, Alexandra Schrader, Kenneth L. Wright, Dieter Kube, Martin Rowe, Ciaran B. Woodman, Paul G. Murray

Blood (2011) 117 (22): 5907–5917.

https://doi.org/10.1182/blood-2010-09-307710

Published: 2011

Includes: Supplemental data

Journal Articles

STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus–encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma

Loránd L. Kis, Natalija Gerasimčik, Daniel Salamon, Emma K. Persson, Noémi Nagy, George Klein, Eva Severinson, Eva Klein

Blood (2011) 117 (1): 165–174.

https://doi.org/10.1182/blood-2010-01-265272

Published: 2011

Includes: Supplemental data

Journal Articles

The Anti-Inflammatory Investigational Agent LMP-420 Demonstrates in Vitro Cytotoxic Activity against Chronic Lymphocytic Leukemia Cells.

Daphne R Friedman, MD, Yvonne Mowery, Margaret Kennedy, Karen M Bond, J. Brice Weinberg, MD, George J Cianciolo, PhD

Blood (2009) 114 (22): 2358.

https://doi.org/10.1182/blood.V114.22.2358.2358

Published: 2009

Journal Articles

Clonal Analysis of the Human Hematopoietic Hierarchy Reveals An Early Lymphoid Progenitor with Extensive Monocytic Potential.

Sergei Doulatov, B.S., Faiyaz Notta, BSc, MSc, John E Dick, PhD

Blood (2009) 114 (22): 1503.

https://doi.org/10.1182/blood.V114.22.1503.1503

Published: 2009

Journal Articles

PR-924, a Selective Inhibitor of the Immunoproteasome Subunit LMP-7 Blocks Multiple Myeloma Cell Growth Both in Vitro and In Vivo.

Ajita V. Singh, Madhavi Bandi, Monette Aujay, Susan Demo, PhD, Teru Hideshima, Nikhil C. Munshi, Paul G. Richardson, Dharminder Chauhan, Ph.D, Kenneth C. Anderson, MD

Blood (2009) 114 (22): 612.

https://doi.org/10.1182/blood.V114.22.612.612

Published: 2009

Journal Articles

Discerning regulation of cis- and trans -presentation of CD8 + T-cell epitopes by EBV-encoded oncogene LMP-1 through self-aggregation

Corey Smith, Naohiro Wakisaka, Tania Crough, Jesse Peet, Tomokazu Yoshizaki, Leone Beagley, Rajiv Khanna

Blood (2009) 113 (24): 6148–6152.

https://doi.org/10.1182/blood-2009-02-203687

Published: 2009

Journal Articles

Coordinate Regulation of NF-κB Subunit Expression in EBV Negative, but Not EBV Positive, Pediatric Hodgkin’s Lymphoma

Terzah M. Horton, MD, PhD, Andrea N Sheehan, MD, Dolores Lopez-Terrada, MD, Robert Edward Hutchison, MD, Sonia Narendra, MD, Meghan A. Higman, MD, PhD, Meng-Fen Wu, PhD, Hao Liu, PhD

Blood (2008) 112 (11): 521.

https://doi.org/10.1182/blood.V112.11.521.521

Published: 2008

Journal Articles

Evidence of Different Subspecies of Microparticles (MP) Derived from Red Blood Cells (RMP) and Comparison of Their Phenotypes and Procoagulant Activity.

Wenche Jy, PhD, Jaehoon Bang, Loreta Bidot, BS, Andrew Lin, Joaquin J. Jimenez, MD, Vincenzo Fontana, MD, Eugene Ahn, MD, Yeon-Soong Ahn, MD

Blood (2006) 108 (11): 1763.

https://doi.org/10.1182/blood.V108.11.1763.1763

Published: 2006

Journal Articles

EBV Related Transformation Events in CLL.

Hazem A. Sayala, MD, Sheila J. O’Connor, PhD, Andrew S. Jack, PhD, Chetan Patalappa, Peter Hillmen, MD, PhD, Roger G. Owen, MD

Blood (2006) 108 (11): 4963.

https://doi.org/10.1182/blood.V108.11.4963.4963

Published: 2006

Journal Articles

IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines

Lorand L. Kis, Miki Takahara, Noemi Nagy, George Klein, Eva Klein

Blood (2006) 107 (7): 2928–2935.

https://doi.org/10.1182/blood-2005-06-2569

Published: 2006

Journal Articles

Impact of LMP-1 expression on clinical outcome in age-defined subgroups of patients with classical Hodgkin lymphoma

Marco Herling, George Z. Rassidakis, Theodoros P. Vassilakopoulos, L. Jeffrey Medeiros, Andreas H. Sarris, on behalf of the International Hodgkin Lymphoma Study Group

Blood (2006) 107 (3): 1240–1241.

https://doi.org/10.1182/blood.V107.3.1240.1240

Published: 2006

Journal Articles

Microparticles Derived from Platelets (PMP), Endothelia (EMP), and Leukocytes (LMP) Exhibit Distinctive Hemostatic and Inflammatory Activities.

Wenche Jy, PhD, Joaquin J. Jimenez, MD, Lawrence L. Horstman, BS, Lucia M. Mauro, BS, Carlos Bidot, Jr., BS, Miriam Yaniz, MS, Martha Gonzalez, MD, Eugene R. Ahn, MD, Carlos J. Bidot, MD, Yeon S. Ahn, MD

Blood (2005) 106 (11): 3699.

https://doi.org/10.1182/blood.V106.11.3699.3699

Published: 2005

Journal Articles

Endothelial Microparticles (EMP) Inhibit ADAMTS13 Activity: Implications in Thrombotic Thrombocytopenic Purpura.

Joaquin J. Jimenez, MD, Wenche Jy, PhD, Lucia M. Mauro, Ana C. Mauro, Laurence L. Horstman, BS, Yeon S. Ahn, MD

Blood (2005) 106 (11): 3676.

https://doi.org/10.1182/blood.V106.11.3676.3676

Published: 2005

Journal Articles

EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX

Thomas Grimm, Sabine Schneider, Elisabeth Naschberger, Jürgen Huber, Eric Guenzi, Arnd Kieser, Peter Reitmeir, Thomas F. Schulz, Cindy A. Morris, Michael Stürzl

Blood (2005) 105 (8): 3263–3269.

https://doi.org/10.1182/blood-2004-07-2752

Published: 2005

Journal Articles

Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma

Jaikumar Duraiswamy, Martina Sherritt, Scott Thomson, Judy Tellam, Leanne Cooper, Geoff Connolly, Mandvi Bharadwaj, Rajiv Khanna

Blood (2003) 101 (8): 3150–3156.

https://doi.org/10.1182/blood-2002-10-3092

Published: 2003

NARROW

Targeting EBV-positive B- and T/NK-cell lymphomas

EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation

Biological Significance of the Immumoproteasome Subunits Mecl-1 and LMP-2 in Diffuse Large B-Cell Lymphoma.

Towards Phase 2/3 Trials for Epstein - Barr Virus (EBV)-Associated Malignancies,

A Functional In Vivo RNAi screen Involving Jumonji C Domain Containing Candidates Unravels Kdm5b As a Negative Modulator of Hematopoietic Stem Cell Self-Renewal

Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas

STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus–encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma

The Anti-Inflammatory Investigational Agent LMP-420 Demonstrates in Vitro Cytotoxic Activity against Chronic Lymphocytic Leukemia Cells.

Clonal Analysis of the Human Hematopoietic Hierarchy Reveals An Early Lymphoid Progenitor with Extensive Monocytic Potential.

PR-924, a Selective Inhibitor of the Immunoproteasome Subunit LMP-7 Blocks Multiple Myeloma Cell Growth Both in Vitro and In Vivo.

Discerning regulation of cis- and trans -presentation of CD8 + T-cell epitopes by EBV-encoded oncogene LMP-1 through self-aggregation

Coordinate Regulation of NF-κB Subunit Expression in EBV Negative, but Not EBV Positive, Pediatric Hodgkin’s Lymphoma

Evidence of Different Subspecies of Microparticles (MP) Derived from Red Blood Cells (RMP) and Comparison of Their Phenotypes and Procoagulant Activity.

EBV Related Transformation Events in CLL.

IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines

Impact of LMP-1 expression on clinical outcome in age-defined subgroups of patients with classical Hodgkin lymphoma

Microparticles Derived from Platelets (PMP), Endothelia (EMP), and Leukocytes (LMP) Exhibit Distinctive Hemostatic and Inflammatory Activities.

Endothelial Microparticles (EMP) Inhibit ADAMTS13 Activity: Implications in Thrombotic Thrombocytopenic Purpura.

EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX

Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only